Table of Contents
- Key Takeaways
- The Evolution of Research into the Health Effects of Vaping Since 2010
- Respiratory Health Findings and Lung Function Studies - risk of Lung Cancer/Lung Disease
- Cardiovascular Impact and Heart Health Research
- Comparative Risk Assessment: E Cigarettes vs. Traditional Smoking
- Quality and Safety Standards in Vaping Products
- Emerging Research Areas and Future Directions
- Vaping Health Effects Study: Current Research and Findings - Conclusion
- FAQ: Vaping Health Effects (2026)
- References
Key Takeaways
-
Less harmful than smoking—but not risk-free – Current consensus shows vaping may be less harmful than traditional cigarettes, especially for smokers who switch, but it still carries measurable health risks and uncertainty around long-term effects.
-
Emerging evidence indicates a risk of COPD from vaping – Recent large-scale reviews suggest e-cigarette use is associated with COPD, though smokers with COPD see lung function improvements when they switch to E-Cigarettes.
-
Cancer concerns are growing despite limited long-term data – New 2026 research indicates vaping may contribute to lung and oral cancers, with studies detecting DNA damage, inflammation, and carcinogenic compounds in vape aerosols.
As vaping continues to evolve as a popular alternative to traditional cigarettes, comprehensive research into its health effects has become increasingly important. With millions of people worldwide having made the switch from smoking to vaping, understanding the scientific evidence behind this transition is crucial for informed decision-making. This article examines the latest findings from vaping health effects studies, providing a balanced overview of current research and its implications for public health.
The Evolution of Research into the Health Effects of Vaping Since 2010
The landscape of vaping research has dramatically expanded since electronic cigarettes first gained popularity in the early 2010s. Initially, studies were limited by the novelty of the technology and the lack of long-term data. However, as vaping devices have matured and user populations have grown, researchers have been able to conduct more comprehensive studies examining both short-term and medium-term health effects. Systematic reviews and meta-analyses are now commonly used to synthesise evidence on vaping health effects, providing a structured and quantitative overview of the current research.
Modern vaping research encompasses several key areas: respiratory health, cardiovascular effects, nicotine delivery systems, and comparative harm reduction when measured against traditional tobacco smoking. The World Health Organization and other international health bodies have been closely monitoring these developments to provide evidence-based guidance to both healthcare professionals and consumers. Many recent studies have undergone peer review, and high-quality reviews often included peer reviewed human studies while they excluded qualitative studies to focus on quantitative data. Qualitative studies are sometimes excluded from main analyses in systematic reviews to ensure the focus remains on measurable health outcomes.
One significant advancement in recent research has been the ability to study cohorts of vapers over multiple years through longitudinal study designs, allowing scientists to observe patterns and trends that were impossible to detect in earlier, shorter-term studies. This longitudinal approach has provided valuable insights into how vaping affects different demographic groups and usage patterns. The process of synthesising evidence relies heavily on robust data analysis and a clear research concept to guide study design and interpretation. Critical revision is also essential in ensuring the accuracy and scientific rigor of published research.
Respiratory Health Findings and Lung Function Studies - risk of Lung Cancer/Lung Disease
Respiratory health remains one of the most scrutinised aspects of vaping research, given the direct inhalation involved in the practice. Recent studies have shown that while vaping is not without risks, the respiratory impact appears significantly different from that of traditional cigarette smoking.
Research conducted on lung function has revealed that former smokers who switched to vaping often experience improvements in respiratory symptoms within months of making the transition (1). Studies measuring forced expiratory volume and other lung capacity metrics have documented measurable improvements in many participants who completely replaced cigarettes with vaping products.
However, researchers have also identified specific concerns related to certain vaping ingredients. The heating of vegetable glycerine and propylene glycol, while generally recognised as safe for ingestion, produces different compounds when vaporised and inhaled. This process generates E Cigarette aerosol, which contains harmful chemicals such as formaldehyde and acrolein. These substances are present at significant levels in some studies and are known to cause irreversible damage, including small airway fibrosis and constrictive bronchiolitis, however the levels present in E-Cigarettes can be anywhere from 10 to 100 times lower than tobacco smoking. (2)
Research indicates that E Cigarette exposure, especially acute exposure, can lead to oxidative stress, DNA damage, and cellular apoptosis, all of which may increase cancer risk. The National Academies of Sciences, Engineering, and Medicine concluded that e-cigarettes emit potentially toxic substances that pose health risks. Vaping has also been linked to severe lung diseases, including lipoid pneumonia and eosinophilic pneumonia (3). Additionally, current vapers have a 39% higher odds of self-reported asthma compared to non-users, and vaping is associated with an increased risk of asthma exacerbation and impaired lung function.
EVALI (e-cigarette or vaping product use-associated lung injury) has been linked to contaminated vaping products, particularly those containing additives like vitamin E acetate. It is important to note that E-Cigarettes made in the UK are prohibited from containing chemicals known to be harmful when inhaled, including vitamin E acetate and diacetyl. Instances of EVALI are almost exclusively existent in the United States (4), where vitamin E acetate has been used to add illicit compounds like THC - the psychoactive component in cannabis - into vape juice.
When comparing study populations, findings show that 'non smoker current vapers' often exhibit different or lower risks for certain biomarkers and diseases compared to 'non vaper current smokers', who continue to smoke conventional cigarettes while using e-cigarettes, highlighting significant differences in risk profiles.
The absence of combustion in vaping eliminates many of the toxic compounds found in cigarette smoke, including tar and carbon monoxide. This fundamental difference has led many researchers to conclude that while vaping may not be completely risk-free, it represents a substantial reduction in respiratory harm compared to smoking traditional cigarettes - a stance adopted by Public Health England and the NHS. (5)
Cardiovascular Impact and Heart Health Research
Cardiovascular research represents another critical area of vaping health studies. There is substantial interest in the cardiovascular effects of vaping, and recent meta-analyses and data analyses have provided new insights into these risks. The relationship between nicotine and heart health has been extensively studied in the context of traditional smoking, but vaping presents a different delivery mechanism that researchers are working to understand fully.
Studies examining heart rate, blood pressure, and arterial function in vapers have produced mixed results compared to smoking. Notably, vaping impairs endothelial function and increases arterial stiffness and blood pressure. Long-term vaping can also impair blood vessel function and raise blood pressure and heart rates. While nicotine itself can cause temporary increases in heart rate and blood pressure, the absence of carbon monoxide and other combustion-related toxins in E-Cigarette vapour appears to reduce some of the cardiovascular risks associated with smoking.
A 2025 meta analysis found that vapers have 53% higher odds of myocardial infarction (heart attack) compared to non-users, indicating a higher risk for heart attacks among e-cigarette users, where smoking is associated with 200% to 400% risk compared with non-smokers.
Additionally, a 2024 NIH data analysis showed that ever-users of e-cigarettes have a 19% increased risk of heart failure, but the median age of the participants in the study was 52, so it is not clear about the associations of previous cigarette smoking on the impact of this figure. (6)
Long-term cardiovascular studies are still ongoing, as researchers require extended observation periods to draw definitive conclusions about heart disease risk. However, preliminary findings suggest that individuals who completely switch from smoking to vaping may experience health improvement in several cardiovascular markers, including improved circulation and reduced inflammation.
It’s important to note that the cardiovascular effects of vaping appear to vary significantly based on the nicotine concentration used and individual health factors. Research continues to explore these variables to provide more personalised health guidance for different user groups.
Comparative Risk Assessment: E Cigarettes vs. Traditional Smoking
One of the most significant contributions of recent vaping research has been comprehensive comparative risk assessments between vaping and traditional cigarette smoking, including regular cigarettes and other tobacco products. Combustible cigarettes are well-known for their carcinogenic risks due to tobacco smoke, which contains numerous toxicants and carcinogens.
Multiple independent research institutions have concluded that vaping presents substantially lower health risks than smoking regular cigarettes and other tobacco products. The Centers for Disease Control and Prevention has acknowledged that while vaping is not risk-free, completely switching from cigarettes to vaping products reduces exposure to many toxicants and carcinogens found in combustible tobacco and tobacco smoke.
Biomarker studies, which examine specific indicators of harm in blood and urine samples, have consistently shown reduced levels of harmful compounds in people who switch from smoking to vaping e-cigarettes or nicotine vaping. These include reduced levels of carbon monoxide, various carcinogens, and inflammatory markers associated with smoking-related diseases.
The concept of harm reduction has become central to public health discussions about vaping. While the ideal scenario involves complete cessation of all nicotine products, research suggests that for individuals unable or unwilling to quit nicotine entirely, nicotine vaping is considered by some as lower-risk alternatives to continued use of combustible cigarettes.
Nicotine is the main addictive substance in tobacco products, including e-cigarettes, and can lead to a cycle of addiction characterised by cravings and withdrawal symptoms. Signs of nicotine addiction include strong cravings, inability to stop using nicotine, and developing a tolerance, as well as irritability which can negatively impact personal relationships and performance in daily activities. Withdrawal symptoms may include anxiety, stress, and depression, often leading individuals to continue using tobacco products to alleviate these feelings. Notably, nicotine exposure before age 25 can permanently harm parts of the brain responsible for attention, learning, and mood control. (7)
When evaluating the evidence, it is important to note that some studies are considered low risk of bias, supporting the validity of their findings. Additionally, health risks associated with vaping and tobacco products may vary across different populations, such as age, sex, gender, ethnicity, and socioeconomic status, influencing health outcomes.
Quality and Safety Standards in Vaping Products
Research into vaping health effects has also highlighted the critical importance of product quality and manufacturing standards. Studies have revealed significant variations in safety profiles between different types of vaping devices and e-liquids, emphasising the need for consistent regulatory oversight and quality control. Notably, fourth-generation vaping devices, which often use high-concentration nicotine salts, have been shown to produce different biological effects on the immune system compared to earlier models.
Manufacturing standards play a crucial role in determining the safety profile of vaping products. Research has shown that products manufactured under pharmaceutical-grade conditions with proper quality controls present different risk profiles compared to unregulated or poorly manufactured alternatives.
The composition of e-liquids has been another focus of safety research. Studies examining various flavouring compounds have identified certain ingredients that may pose respiratory risks when inhaled regularly. This research has informed regulatory decisions about which compounds should be restricted or banned in vaping products.
Temperature control and device design have also emerged as important factors in safety research. Studies have shown that overheating coils can produce harmful compounds, leading to improved device designs that better regulate temperature and prevent dangerous heating conditions. Studies have also found significant differences and significant levels of harmful compounds depending on device type and vaping frequency, highlighting the importance of both product design and user behaviour in determining health risks.
Emerging Research Areas and Future Directions
As vaping research continues to mature, several emerging areas of study are providing new insights into long-term health effects and optimal harm reduction strategies. Genetic research is beginning to explore how individual genetic variations might affect responses to vaping, potentially leading to more personalised health recommendations.
Environmental health research is examining the secondhand exposure risks associated with vaping, with studies generally finding significantly lower levels of harmful compounds in E-Cigarette vapour compared to secondhand cigarette smoke. This research is informing policy decisions about indoor vaping regulations and workplace policies, with guidance from organisations such as Health Canada and other national institutes.
Longitudinal and human studies tracking vapers over extended periods are beginning to provide data on very long-term health outcomes. While comprehensive results are still years away, early indicators continue to support the harm reduction potential of vaping compared to continued smoking. However, authoritative reports from the National Academies and publications from the National Academies Press emphasise the need for future research, particularly more robust human studies, to address gaps in knowledge about cancer and cardiovascular risks.
Research into cessation effectiveness is also expanding, with studies examining how vaping can be integrated into comprehensive smoking cessation and addiction programs. The National Health Service and other healthcare systems are incorporating this research into evidence-based treatment protocols, aiming for health improvement among those who quit smoking, backed up by studies such as one from Cochrane Library finding that E-Cigarettes are more effective for quitting smoking than traditional nicotine replacement therapy. (8)
Vaping Health Effects Study: Current Research and Findings - Conclusion
Current vaping health effects research presents a nuanced picture of an evolving field with significant implications for public health policy and individual decision-making. While studies consistently indicate that vaping is not completely risk-free, the substantial body of evidence suggests it represents a significant harm reduction opportunity for individuals who would otherwise continue smoking traditional cigarettes.
The research emphasises the importance of complete transition from smoking to vaping rather than dual use, as the health benefits appear most pronounced when combustible tobacco is eliminated entirely, and are potentially mitigated completely with dual use. Quality and manufacturing standards emerge as critical factors in determining safety profiles, highlighting the value of regulated, professionally manufactured products.
As research continues to evolve, the scientific community maintains that while vaping should not be initiated by non-smokers, particularly young people, it represents a valuable tool for harm reduction among current smokers. The ongoing development of safety standards, improved device technology, and comprehensive regulatory frameworks will likely continue to enhance the safety profile of vaping products while maximising their potential as smoking cessation aids.
For individuals considering vaping as an alternative to smoking, consulting with healthcare professionals and choosing high-quality, regulated products remains essential. The research landscape continues to develop, and staying informed about the latest findings helps ensure that decisions about vaping are based on the most current scientific evidence available.
If you are a smoker and looking to quit, or have tried unsuccessfully in the past, then switching to E-Cigarettes can lead to reduced health risks, improved finances and can function as a stepping-stone to quitting nicotine altogether. Check out the SMOKO E-Cigarette and Vape Starter Kit deals and make the switch today!
FAQ: Vaping Health Effects (2026)
Is vaping safe?
No—while generally considered less harmful than smoking, vaping is not entirely risk-free and can still impact lung, heart, and overall health.
Can vaping cause long-term health problems?
Potentially yes. Research is still developing, but studies suggest links to respiratory issues, cardiovascular effects, and possible long-term disease risks.
Does vaping cause cancer?
There’s no definitive long-term evidence yet, but recent studies show exposure to carcinogens and DNA damage, which raises concern about increased cancer risk over time.
Is vaping better than smoking cigarettes?
For current smokers, switching completely to vaping is widely considered less harmful—but it’s not recommended for non-smokers.
What do we still not know about vaping?
Because vaping is relatively new, the full long-term health effects (over decades) are still unclear and under active research.
References
(3) What Does Vaping Do to Your Lungs?
(4) American Lung Association Responds to Vitamin E Acetate Findings in CDC EVALI Investigation
(5) NHS: Using e-cigarettes to stop smoking
(6) Vaping Linked to Higher Risk of HFpEF, NIH Data Show
(7) Nicotine and the young brain
ABOUT THE AUTHOR
Written by Dan Overgage
Dan Overgage is a former smoker of 10 years until he became a client of SMOKO E-Cigarettes. Dan started working with SMOKO 5 years ago after successfully quitting using our e-cigarettes and works across our Customer Service and heads up our content creation and research with a strong focus on all things quitting smoking. During his tenure with SMOKO, Dan has written countless blogs and consults with countless clients every day to help them to stay smoke-free.
Last updated 01/05/2026
